Tounjian Advisory Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AMGN
Tounjian Advisory Partners's AMGN Position: Q2 2026 in Review
Tounjian Advisory Partners opened a new position in Amgen (AMGN) in Q2 2026: 35 shares worth $12.8K. The stake represents 0.01% of the portfolio and ranks #348 among its holdings. This is a return to the name: Tounjian Advisory Partners previously reported a position in AMGN as recently as Q2 2025.
Tounjian Advisory Partners first reported a position in AMGN in Q1 2025 and has held it in 3 quarters since. The position peaked at $1.36M in Q1 2025. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- Tounjian Advisory Partners held 35 shares of Amgen worth $12.8K as of Q2 2026.
- Amgen was a new Tounjian Advisory Partners position in Q2 2026.
- Amgen made up 0.01% of Tounjian Advisory Partners's portfolio in Q2 2026, its #348 holding.
- Tounjian Advisory Partners first reported a position in Amgen in Q1 2025 and has held it in 3 quarters since.
- Tounjian Advisory Partners's Amgen position peaked at $1.36M in Q1 2025.
- 3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on Tounjian Advisory Partners's 13F filing for Q2 2026, filed 7 Aug 2026.